ორშაბათი, აპრილი 13, 2026
- Advertisement -
Google search engine
Global Ingredient Risk Index Metabolic

Whey Protein Isolate

Whey protein isolate (bovine milk whey)

Also known as: WPI, whey isolate, whey protein, milk whey isolate

LOW RISK 3.0/10 How?

This ingredient is classified as unclassified risk (GIRI score: 3.0/10).

02

Safety Profile

Known Safety Concerns

  • Dairy allergy -- absolute contraindication
  • Heavy metal contamination in some protein powders -- choose tested brands
  • High protein intake may stress kidneys in pre-existing kidney disease
  • May increase acne in some individuals

Contraindications

  • Dairy allergy -- absolute contraindication
  • Heavy metal contamination in some protein powders -- choose tested brands
═══════════════════════════════════════════════════════════════════════ -->
03

Interactions

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
04

Evidence and Scientific Findings

Overview

Ingredient Overview

Whey protein isolate is highly purified milk whey with most lactose removed (typically >90% protein). Extensively studied with excellent safety profile for healthy adults. Contraindicated in dairy and milk allergy. Lactose intolerant individuals usually tolerate WPI better than concentrate. Heavy metals in protein powders are a quality concern — choose tested brands.

Classification

Biological and Chemical Classification

Scientific Name
Whey protein isolate (bovine milk whey)
Mechanism

Mechanism of Action

Information not yet available for this ingredient profile.

Clinical Evidence

Clinical Evidence of Effectiveness

Information not yet available for this ingredient profile.

Pharmacokinetics

Pharmacokinetics

Information not yet available for this ingredient profile.

Dosage

Recommended Dosage

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
05

SETI — Scientific Evidence Transparency Index

SETI Score 50/100
Risk Level High risk
Scientific Confidence Low
Evidence Strength Limited
Key Benefit Metabolic
Key Safety Concern Dairy allergy -- absolute contraindication
Evidence Reviewed 10 PubMed studies
Scientific Confidence Low
Based on study quality, consistency, and recency

Executive Summary — Ingredient Assessment

SETI Score 50/100
Risk Level High risk
Evidence Strength Limited
Main Benefit Metabolic
Main Safety Concern Dairy allergy -- absolute contraindication
Ingredient Whey Protein Isolate
Scientific name Whey protein isolate (bovine milk whey)
Scientific Evidence Overview
  • 10 studies reviewed
  • 0 high-quality studies (meta-analysis or RCT)
  • Main clinical benefit observed: Metabolic
  • Evidence consistency: High consistency across studies (100%)
Safety Signals
  • Dairy allergy -- absolute contraindication
  • Heavy metal contamination in some protein powders -- choose tested brands
  • High protein intake may stress kidneys in pre-existing kidney disease
  • May increase acne in some individuals
Evidence Strength Limited
Final Scientific Assessment

The available scientific evidence for Whey Protein Isolate indicates notable safety signals that warrant caution. Use should be considered carefully and monitored, particularly in sensitive populations or alongside other medications.

Ingredient Whey Protein Isolate
Evidence reviewed 10 peer-reviewed studies (last 10 years)
Scientific name Whey protein isolate (bovine milk whey)
50 /100

Total SETI Score

High risk
Evidence quality 10/40
Evidence consistency 20/20
Safety signals 0/20
Study recency 10/10
Evidence transparency 10/10

Evidence Summary

  • 10 studies reviewed
  • 0 high-quality studies (meta-analysis or systematic review)
  • 0 studies identified benefits or no safety concern (GREEN)
  • 10 studies reported limited or advisory safety evidence (YELLOW)

Evidence Policy

Only peer-reviewed scientific literature indexed in PubMed or comparable databases is included in this evaluation. Commercial websites, blogs, and marketing materials are excluded. All references include direct traceable links to source documents.

Last updated: 25 მარ 2026, 17:57

Evidence Distribution

10 Other / unclassified
  1. Observational / other LOW evidence YELLOW
    Influence of Stabilizers, Milk Proteins, and Heat Treatment on the Tribology and Rheology of Drinking Yogurt. ↗
    Journal J Food Sci
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Zhang X et al.. Influence of Stabilizers, Milk Proteins, and Heat Treatment on the Tribology and Rheology of Drinking Yogurt.. J Food Sci. 2026. PMID:41858095.
  2. Observational / other LOW evidence YELLOW
    Effect of molecular weight, temperature, and pH on antioxidant activity of whey protein isolate hydrolysate and its application in pasta fortification. ↗
    Journal Sci Rep
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Mohammadi M et al.. Effect of molecular weight, temperature, and pH on antioxidant activity of whey protein isolate hydrolysate and its application in pasta fortification.. Sci Rep. 2026. PMID:41857221.
  3. Observational / other LOW evidence YELLOW
    Changes in structure, digestion, and curcumin release properties of starch constructed by protein fibrils-OSA starch interactions. ↗
    Journal Food Chem
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Jin D et al.. Changes in structure, digestion, and curcumin release properties of starch constructed by protein fibrils-OSA starch interactions.. Food Chem. 2026. PMID:41850104.
  4. Observational / other LOW evidence YELLOW
    High freeze-thaw stability of Pickering emulsion stabilized by WPI-carboxymethyl cellulose particles and its effect on frozen pork patties as a fat substitute. ↗
    Journal Food Sci Anim Resour
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Zhang HY et al.. High freeze-thaw stability of Pickering emulsion stabilized by WPI-carboxymethyl cellulose particles and its effect on frozen pork patties as a fat substitute.. Food Sci Anim Resour. 2026. PMID:41849097.
  5. Observational / other LOW evidence YELLOW
    Oxidative stability and growth-promoting effect for Lactobacillus acidophilus ATCC 43121 of whey protein isolate/inulin Maillard conjugates-based nanoemulsion delivery system containing fish oil. ↗
    Journal Food Sci Anim Resour
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Kim YW et al.. Oxidative stability and growth-promoting effect for Lactobacillus acidophilus ATCC 43121 of whey protein isolate/inulin Maillard conjugates-based nanoemulsion delivery system containing fish oil.. Food Sci Anim Resour. 2026. PMID:41848984.
  6. Observational / other LOW evidence YELLOW
    Modification of Whey Protein Isolate with Surfactants Based on Hofmeister Series and Interaction Parameter. ↗
    Journal ACS Omega
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Lopes JS et al.. Modification of Whey Protein Isolate with Surfactants Based on Hofmeister Series and Interaction Parameter.. ACS Omega. 2026. PMID:41835604.
  7. Observational / other LOW evidence YELLOW
    Whey protein isolate-based amphiphilic surfactin complexes: Structural, antioxidant, and interfacial properties, and molecular docking analysis. ↗
    Journal Int J Biol Macromol
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Pan Y et al.. Whey protein isolate-based amphiphilic surfactin complexes: Structural, antioxidant, and interfacial properties, and molecular docking analysis.. Int J Biol Macromol. 2026. PMID:41831508.
  8. Observational / other LOW evidence YELLOW
    Cellulose Nanocrystals-Stabilized Acidic W(1)/O/W(2) Emulsions for Anthocyanins Encapsulation. ↗
    Journal Foods
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Wu J et al.. Cellulose Nanocrystals-Stabilized Acidic W(1)/O/W(2) Emulsions for Anthocyanins Encapsulation.. Foods. 2026. PMID:41829172.
  9. Observational / other LOW evidence YELLOW
    Formulation and Characterization of Nutrient-Dense Medjool Date Bars: Integration of Proteins, Bioactives, and Processing Stability for Functional Snack Innovation. ↗
    Journal Foods
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Bahloul AH et al.. Formulation and Characterization of Nutrient-Dense Medjool Date Bars: Integration of Proteins, Bioactives, and Processing Stability for Functional Snack Innovation.. Foods. 2026. PMID:41829160.
  10. Observational / other LOW evidence YELLOW
    Modulating Casein-Stabilized Emulsions Through the Incorporation of Different Emulsifiers: Impacts on Microstructure and Oral Tribology. ↗
    Journal Foods
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Ji S et al.. Modulating Casein-Stabilized Emulsions Through the Incorporation of Different Emulsifiers: Impacts on Microstructure and Oral Tribology.. Foods. 2026. PMID:41829119.
═══════════════════════════════════════════════════════════════════════ -->
06

Score Transparency

Q × L × D × S × 10 = 3.0 / 10

The GIRI Score is the product of four independently computed evidence components, each normalised to 0–1, then scaled to 0–10. Every component is derived exclusively from peer-reviewed references and regulatory data — no editorial judgement is applied.

Q
Evidence Quantity 0 / 10
0%

0 of 10 approved references (score saturates at 10). More peer-reviewed studies = stronger evidence base.

Method: Q = number of approved references ÷ 10 (capped at 1.0)

L
Evidence Quality 5 / 10
50%

Limited — mostly case reports or animal studies

Method: L = mean study-level weight across approved references. Level 1 (meta-analysis / systematic review) = 1.0; Level 2 (RCT) = 0.8; Level 3 (cohort/case-control) = 0.6; Level 4 (case report) = 0.4; Level 5 (animal / in-vitro) = 0.2.

D
Evidence Direction 5 / 10
Benefit
Risk
50%

Mixed or neutral — roughly equal benefit and risk signals

Method: D = (sum of risk-scored references − sum of benefit-scored references) ÷ total evidence score, then scaled from [−1, 1] to [0, 1]. 0.0 = pure benefit; 0.5 = neutral; 1.0 = pure risk.

S
Safety Signals 5 / 10
50%

One or more monitoring-level safety signals active

Method: S = 0.5 (neutral baseline) + sum of active signal severity deltas ÷ 10. Severity deltas: Critical = +2.0, High = +1.5, Moderate = +1.0, Low = +0.5. Capped at 1.0.

0Q × 5L × 5D × 5S = 3.0 / 10

Final GIRI Score for Whey Protein Isolate. Risk level thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.

Full methodology & data sources

The GIRI Score is computed entirely from structured data — no editorial scoring or subjective weighting is applied at any step.

  • References: Only approved references are counted. Each reference is assigned an evidence level (L1–L5) and a direction (risk / neutral / benefit) by the reference manager or AI classifier.
  • Safety Signals: Sourced from regulatory agencies (FDA, EMA, Health Canada, TGA, and others) and pharmacovigilance databases. Only active signals count toward the score.
  • Formula version: GIRI Score v3.7.0 — Q × L × D × S × 10.
  • Limitations: The score reflects published evidence and recorded signals as of the last update date. It is not a clinical risk assessment and should not replace advice from a qualified healthcare professional.
07

Risk Level Classification

LOW RISK 3.0/10

Based on available regulatory signals and scientific evidence, this ingredient presents a low safety concern under normal conditions of use.

LOW
0–3.0
MODERATE
3.0–5.5
HIGH
5.5–7.5
CRITICAL
7.5–10
3.0

The score pin shows exactly where this ingredient falls on the fixed risk scale.

What drove the Low classification for Whey Protein Isolate

GIRI Score 3.0 / 10

A score of 3.0 places this ingredient in the Low band. Thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.

Evidence Quantity (Q) 0 / 10 refs

0 approved references.

Evidence Quality (L) 50%

Limited — mostly case reports or animal studies (Level 4–5).

Evidence Direction (D) 50% toward risk

Neutral or mixed — benefit and risk signals roughly balanced.

Safety Signals (S) 0 active signals

No active signals — S component is at neutral baseline (0.5), contributing no extra risk weight.

Regulatory Status No restrictions found

No major regulatory restrictions or advisories recorded across monitored jurisdictions (FDA, EMA, Health Canada, TGA, and others).

How are the Low / Moderate / High / Critical thresholds defined?

The four risk levels are fixed score bands. A score is assigned to exactly one level based on where it falls:

LevelScoreMeaning
LOW0.0 – 2.9Sparse or predominantly beneficial evidence. No active safety alerts.
MODERATE3.0 – 5.4Mixed signals — some risk alongside benefit. Caution at high doses or in sensitive groups.
HIGH5.5 – 7.4Multiple studies or regulatory alerts documenting adverse effects. Professional oversight recommended.
CRITICAL7.5 – 10Regulatory restrictions in one or more major jurisdictions. Serious documented harm. Avoid without specialist supervision.

Thresholds are fixed constants (GIRI_Score_Utils::LEVEL_THRESHOLDS). They do not change per ingredient and are never subject to editorial adjustment.